Tag Archives: FINRA

Legal Insider Trading Biotech

Let’s say a biotech CEO learns that, in two days, her company is going to announce clinical results that will surely boost its stock price. She can’t legally buy up a bunch of the company’s shares right then — that would be the bad kind of insider trading — but she can cancel a scheduled 10b5-1 sale to avoid dumping stock just before its price soars.

https://www.statnews.com/2016/08/08/insider-trading-biotech/

Advertisements